List of Tables
Table 1. Global Irritable Bowel Syndrome Medication Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Irritable Bowel Syndrome with Constipation
Table 3. Key Players of lrritable Bowel Syndrome with Diarrhea
Table 4. Key Players of lrritable Bowel Syndrome with alternating Constipationand Diarrhea
Table 5. Global Irritable Bowel Syndrome Medication Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Irritable Bowel Syndrome Medication Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Irritable Bowel Syndrome Medication Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Irritable Bowel Syndrome Medication Market Share by Region (2020-2025)
Table 9. Global Irritable Bowel Syndrome Medication Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Irritable Bowel Syndrome Medication Market Share by Region (2026-2031)
Table 11. Irritable Bowel Syndrome Medication Market Trends
Table 12. Irritable Bowel Syndrome Medication Market Drivers
Table 13. Irritable Bowel Syndrome Medication Market Challenges
Table 14. Irritable Bowel Syndrome Medication Market Restraints
Table 15. Global Irritable Bowel Syndrome Medication Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Irritable Bowel Syndrome Medication Market Share by Players (2020-2025)
Table 17. Global Top Irritable Bowel Syndrome Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Medication as of 2024)
Table 18. Ranking of Global Top Irritable Bowel Syndrome Medication Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Irritable Bowel Syndrome Medication Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Irritable Bowel Syndrome Medication, Headquarters and Area Served
Table 21. Global Key Players of Irritable Bowel Syndrome Medication, Product and Application
Table 22. Global Key Players of Irritable Bowel Syndrome Medication, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Irritable Bowel Syndrome Medication Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Irritable Bowel Syndrome Medication Revenue Market Share by Type (2020-2025)
Table 26. Global Irritable Bowel Syndrome Medication Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Irritable Bowel Syndrome Medication Revenue Market Share by Type (2026-2031)
Table 28. Global Irritable Bowel Syndrome Medication Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Irritable Bowel Syndrome Medication Revenue Market Share by Application (2020-2025)
Table 30. Global Irritable Bowel Syndrome Medication Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Irritable Bowel Syndrome Medication Revenue Market Share by Application (2026-2031)
Table 32. North America Irritable Bowel Syndrome Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Irritable Bowel Syndrome Medication Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Irritable Bowel Syndrome Medication Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Irritable Bowel Syndrome Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Irritable Bowel Syndrome Medication Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Irritable Bowel Syndrome Medication Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Irritable Bowel Syndrome Medication Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Irritable Bowel Syndrome Medication Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Irritable Bowel Syndrome Medication Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Irritable Bowel Syndrome Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Irritable Bowel Syndrome Medication Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Irritable Bowel Syndrome Medication Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Irritable Bowel Syndrome Medication Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Irritable Bowel Syndrome Medication Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Irritable Bowel Syndrome Medication Market Size by Country (2026-2031) & (US$ Million)
Table 47. Bausch Health Company Details
Table 48. Bausch Health Business Overview
Table 49. Bausch Health Irritable Bowel Syndrome Medication Product
Table 50. Bausch Health Revenue in Irritable Bowel Syndrome Medication Business (2020-2025) & (US$ Million)
Table 51. Bausch Health Recent Development
Table 52. Sucampo Pharmaceuticals Company Details
Table 53. Sucampo Pharmaceuticals Business Overview
Table 54. Sucampo Pharmaceuticals Irritable Bowel Syndrome Medication Product
Table 55. Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2020-2025) & (US$ Million)
Table 56. Sucampo Pharmaceuticals Recent Development
Table 57. Abbott Laboratories Company Details
Table 58. Abbott Laboratories Business Overview
Table 59. Abbott Laboratories Irritable Bowel Syndrome Medication Product
Table 60. Abbott Laboratories Revenue in Irritable Bowel Syndrome Medication Business (2020-2025) & (US$ Million)
Table 61. Abbott Laboratories Recent Development
Table 62. Lexicon Pharmaceuticals Company Details
Table 63. Lexicon Pharmaceuticals Business Overview
Table 64. Lexicon Pharmaceuticals Irritable Bowel Syndrome Medication Product
Table 65. Lexicon Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2020-2025) & (US$ Million)
Table 66. Lexicon Pharmaceuticals Recent Development
Table 67. Salix Pharmaceuticals Company Details
Table 68. Salix Pharmaceuticals Business Overview
Table 69. Salix Pharmaceuticals Irritable Bowel Syndrome Medication Product
Table 70. Salix Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2020-2025) & (US$ Million)
Table 71. Salix Pharmaceuticals Recent Development
Table 72. lronwood Pharmaceuticals Company Details
Table 73. lronwood Pharmaceuticals Business Overview
Table 74. lronwood Pharmaceuticals Irritable Bowel Syndrome Medication Product
Table 75. lronwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Medication Business (2020-2025) & (US$ Million)
Table 76. lronwood Pharmaceuticals Recent Development
Table 77. GlaxoSmithKline Company Details
Table 78. GlaxoSmithKline Business Overview
Table 79. GlaxoSmithKline Irritable Bowel Syndrome Medication Product
Table 80. GlaxoSmithKline Revenue in Irritable Bowel Syndrome Medication Business (2020-2025) & (US$ Million)
Table 81. GlaxoSmithKline Recent Development
Table 82. Allergan Company Details
Table 83. Allergan Business Overview
Table 84. Allergan Irritable Bowel Syndrome Medication Product
Table 85. Allergan Revenue in Irritable Bowel Syndrome Medication Business (2020-2025) & (US$ Million)
Table 86. Allergan Recent Development
Table 87. Research Programs/Design for This Report
Table 88. Key Data Information from Secondary Sources
Table 89. Key Data Information from Primary Sources
Table 90. Authors List of This Report
List of Figures
Figure 1. Irritable Bowel Syndrome Medication Picture
Figure 2. Global Irritable Bowel Syndrome Medication Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Irritable Bowel Syndrome Medication Market Share by Type: 2024 VS 2031
Figure 4. Irritable Bowel Syndrome with Constipation Features
Figure 5. lrritable Bowel Syndrome with Diarrhea Features
Figure 6. lrritable Bowel Syndrome with alternating Constipationand Diarrhea Features
Figure 7. Global Irritable Bowel Syndrome Medication Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Irritable Bowel Syndrome Medication Market Share by Application: 2024 VS 2031
Figure 9. Hospitals Case Studies
Figure 10. Clinics Case Studies
Figure 11. Homecare Settings Case Studies
Figure 12. Irritable Bowel Syndrome Medication Report Years Considered
Figure 13. Global Irritable Bowel Syndrome Medication Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Irritable Bowel Syndrome Medication Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Irritable Bowel Syndrome Medication Market Share by Region: 2024 VS 2031
Figure 16. Global Irritable Bowel Syndrome Medication Market Share by Players in 2024
Figure 17. Global Top Irritable Bowel Syndrome Medication Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Irritable Bowel Syndrome Medication as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Irritable Bowel Syndrome Medication Revenue in 2024
Figure 19. North America Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Irritable Bowel Syndrome Medication Market Share by Country (2020-2031)
Figure 21. United States Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Irritable Bowel Syndrome Medication Market Share by Country (2020-2031)
Figure 25. Germany Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Irritable Bowel Syndrome Medication Market Share by Region (2020-2031)
Figure 33. China Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Irritable Bowel Syndrome Medication Market Share by Country (2020-2031)
Figure 41. Mexico Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Irritable Bowel Syndrome Medication Market Share by Country (2020-2031)
Figure 45. Turkey Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Irritable Bowel Syndrome Medication Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Bausch Health Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2020-2025)
Figure 49. Sucampo Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2020-2025)
Figure 50. Abbott Laboratories Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2020-2025)
Figure 51. Lexicon Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2020-2025)
Figure 52. Salix Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2020-2025)
Figure 53. lronwood Pharmaceuticals Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2020-2025)
Figure 54. GlaxoSmithKline Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2020-2025)
Figure 55. Allergan Revenue Growth Rate in Irritable Bowel Syndrome Medication Business (2020-2025)
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
